Medical College, Yangzhou Uniersity, Yangzhou 225001, China.
Deparment of Gynecology, People's Hospital of Jingjiang, Jingjiang 214500, China.
J Healthc Eng. 2022 Apr 11;2022:5606998. doi: 10.1155/2022/5606998. eCollection 2022.
In order to determine the clinical efficacy of laparoendoscopic single-site surgery (LESS) for uterine fibroids (UFs), the study population comprises 65 patients who underwent hysteromyoma enucleation in our hospital from January 2020 to September 2021. Among them, 30 patients with conventional multiport laparoscopic myomectomy (MLS-M) are taken as the control group (CG), and the rest 35 patients with laparoendoscopic single-site myomectomy (LESS-M) are taken as the research group (RG). Perioperative indicators and incidence of complications are compared between groups. Measurements of inflammatory factors (IFs) (tumor necrosis factor (TNF)-, interleukin (IL)-6, and C-reactive protein (CRP)) as well as ovarian function indices (follicle stimulating hormone (FSH), luteinizing hormone (LH), and estradiol (E2)) were carried out by using ELISA. Patients' pain sensation, body image satisfaction, incision aesthetic satisfaction, and quality of life (QOL) are assessed using the Visual Analogue Scale (VAS), Body Image Scale (BIS), Cosmetic Score (CS), and SF-36, respectively. LESS-M is beneficial to patients' early recovery after operation, with little influence on ovarian function and high incision aesthetic satisfaction, which reserves clinical popularization.
为了确定腹腔镜单孔手术（LESS）治疗子宫肌瘤（UFs）的临床疗效，本研究纳入了 2020 年 1 月至 2021 年 9 月在我院接受子宫肌瘤剔除术的 65 例患者。其中，30 例行传统多孔腹腔镜子宫肌瘤剔除术（MLS-M）的患者作为对照组（CG），其余 35 例行腹腔镜单孔子宫肌瘤剔除术（LESS-M）的患者作为观察组（RG）。比较两组患者的围手术期指标和并发症发生率。采用酶联免疫吸附试验（ELISA）检测两组患者的炎症因子（TNF-、IL-6 和 CRP）和卵巢功能指标（FSH、LH 和 E2）。采用视觉模拟评分法（VAS）、体像量表（BIS）、美容评分（CS）和 SF-36 分别评估患者的疼痛感知、体像满意度、切口美观满意度和生活质量（QOL）。LESS-M 有利于患者术后的早期恢复，对卵巢功能影响小，切口美观满意度高，具有临床推广价值。
